Confidential

A Canadian asset manager has completed the sale of its dental laboratory platform to a US private equity-backed purchaser.

The platform comprised dental laboratory businesses operating across British Columbia, Alberta, Ontario and Atlantic Canada. The transaction represents the successful culmination of a six-plus-year buy-and-build strategy in the dental laboratory sector, and a significant private equity exit in the Canadian dental services market.

Led by our Toronto office, Norton Rose Fulbright advised on all aspects of the transaction, including the negotiation and settlement of the share purchase agreement, the rollover equity arrangements under which certain sellers invested in the purchaser’s holding company, healthcare regulatory requirements and approvals, and tax structuring.

The cross-border nature of the transaction, the complexity of the multi-entity structure and the earnout mechanics required sophisticated legal advice across corporate, tax, employment, regulatory and other disciplines.

Contact